{"id":516020,"date":"2020-11-06T18:32:01","date_gmt":"2020-11-06T18:32:01","guid":{"rendered":"https:\/\/www.abnewswire.com\/pressreleases\/?p=516020"},"modified":"2020-11-06T18:32:01","modified_gmt":"2020-11-06T18:32:01","slug":"veterinary-vaccines-market-worth-113-billion-by-2025-key-players-zoetis-us-merck-us-boehringer-ingelheim-germany","status":"publish","type":"post","link":"https:\/\/www.abnewswire.com\/pressreleases\/veterinary-vaccines-market-worth-113-billion-by-2025-key-players-zoetis-us-merck-us-boehringer-ingelheim-germany_516020.html","title":{"rendered":"Veterinary Vaccines Market Worth $11.3 Billion by 2025 | Key Players Zoetis (US), Merck (US), Boehringer Ingelheim (Germany)"},"content":{"rendered":"<div style=\"float:right;  width:250px; padding:8px 10px 10px 10px;\"><a href=\"https:\/\/www.abnewswire.com\/uploads\/1604646517.jpeg\" style=\"border:none !important;\" target=\"_blank\" rel=\"nofollow\" ><img loading=\"lazy\" decoding=\"async\" class=\"alignnone size-medium wp-image-29\" title=\"Veterinary Vaccines Market Worth $11.3 Billion by 2025 | Key Players Zoetis (US), Merck (US), Boehringer Ingelheim (Germany)\" src=\"https:\/\/www.abnewswire.com\/uploads\/1604646517.jpeg\" alt=\"Veterinary Vaccines Market Worth $11.3 Billion by 2025 | Key Players Zoetis (US), Merck (US), Boehringer Ingelheim (Germany)\" width=\"225\" height=\"225\" \/><\/a><\/div>\n<div style=\"font-style:italic; padding:8px 0px;\">Veterinary Vaccines Market Size Estimation and Analysis of Wide Range of Growth Opportunities for Industry Players.<\/div>\n<p style=\"text-align: justify;\">According to the new market research report&nbsp;<strong>&#8220;Veterinary Vaccines Market by Disease (Swine Pneumonia, Avian Influenza, Rabies, Coccidiosis, Brucellosis, Canine Distemper), Type (Poultry, Livestock, Aquaculture, Porcine, Canine), Technology (Inactivated, Toxoid, Recombinant) &#8211; Global Forecast to 2025&#8221;,&nbsp;<\/strong>published by MarketsandMarkets&trade;, t<strong>he global Veterinary Vaccines Market is projected to grow at a CAGR of 7.2% during the forecast period to reach&nbsp;<span class=\"xn-money\">USD 11.3 billion<\/span>&nbsp;by 2025 from&nbsp;<span class=\"xn-money\">USD 8.0 billion<\/span>&nbsp;in 2020.<\/p>\n<p><\/strong><strong>Download PDF Brochure:<br \/><\/strong><a href=\"https:\/\/www.marketsandmarkets.com\/pdfdownloadNew.asp?id=1233&amp;utm_source=prnewswire&amp;utm_medium=referral&amp;utm_campaign=paidpr\" rel=\"nofollow noopener\" target=\"_blank\">https:\/\/www.marketsandmarkets.com\/pdfdownloadNew.asp?id=1233<\/a><\/p>\n<p>Factors such as the rising incidence of zoonotic diseases, growth in the companion animal population, initiatives by various government agencies and animal associations to maintain animal health, and the increasing demand for animal-derived food products are driving the growth of this market.<\/p>\n<p style=\"text-align: justify;\">\n<p><img decoding=\"async\" src=\"https:\/\/pressrelease.icrowdnewswire.com\/assets\/source\/users\/1902\/animal-veterinary-vaccines-market7.jpg?1604646317633\" alt=\"animal-veterinary-vaccines-market7\" \/><\/p>\n<p style=\"text-align: justify;\"><strong>The live attenuated vaccines segment accounted for the largest share of the veterinary vaccines market.<\/p>\n<p><\/strong>Based on technology, the veterinary vaccines market is segmented into live attenuated vaccines, inactivated vaccines, toxoid vaccines, recombinant vaccines, and other vaccines. The live attenuated vaccines segment accounted for the largest share of the veterinary vaccines market in 2019, majorly due to the ease of administration and long-term immunity offered by these vaccines.<\/p>\n<p><strong><em>Browse&nbsp;in-depth TOC on<\/em>&nbsp;&#8220;<a href=\"https:\/\/www.marketsandmarkets.com\/Market-Reports\/animal-veterinary-vaccines-market-1233.html\" rel=\"nofollow noopener\" target=\"_blank\">Veterinary Vaccines Market<\/a>&#8220;<\/p>\n<p><\/strong>238 &ndash; Tables<br \/>25 &ndash; Figures &nbsp;<br \/>180 &ndash; Pages<\/p>\n<p><strong>The porcine circovirus II segment accounted for the largest share of the porcine vaccines market in 2019.<\/p>\n<p><\/strong>Based on disease, the porcine vaccines market is segmented into porcine reproductive and respiratory syndrome (PRRS), porcine circovirus II, porcine parvovirus, swine influenza, swine pneumonia, and other porcine diseases. In 2019, the porcine circovirus II segment dominated this market owing to the high and growing prevalence of the infection<\/p>\n<p><strong><span class=\"xn-location\">North America<\/span>&nbsp;to dominate the neuromodulation market during the forecast period<\/p>\n<p><\/strong>In 2019,&nbsp;<span class=\"xn-location\">North America<\/span>&nbsp;dominated the veterinary vaccines market, followed by&nbsp;<span class=\"xn-location\">Europe<\/span>. The major factors driving the growth of this market include the increasing animal population, growing animal disease prevalence, rising awareness on veterinary vaccines, and the high and increasing demand for animal products in the region.<\/p>\n<p><strong>Request Sample Repprt:<br \/><\/strong><a href=\"https:\/\/www.marketsandmarkets.com\/requestsampleNew.asp?id=1233\">https:\/\/www.marketsandmarkets.com\/requestsampleNew.asp?id=1233<\/a>&nbsp;<\/p>\n<p>The prominent players in this market include Zoetis (US), Merck Animal Health (US), Boehringer Ingelheim (<span class=\"xn-location\">Germany<\/span>), Elanco (US), Ceva (US), Virbac (<span class=\"xn-location\">France<\/span>), Vetoquinol (<span class=\"xn-location\">France<\/span>), Phibro Animal Health (US), Hester Biosciences (<span class=\"xn-location\">India<\/span>), HIPRA (<span class=\"xn-location\">Spain<\/span>), Biogenesis Bago (<span class=\"xn-location\">Argentina<\/span>), Tianjin Ringpu (<span class=\"xn-location\">China<\/span>), China Animal Husbandry (<span class=\"xn-location\">China<\/span>), Jinyu Biotechnology (<span class=\"xn-location\">China<\/span>), and Endovac Animal Health (US).<\/p>\n<p><span style='font-size:18px !important;'>Media Contact<\/span><br \/><strong>Company Name:<\/strong> <a href=\"https:\/\/www.abnewswire.com\/companyname\/marketsandmarkets.com_17712.html\" rel=\"nofollow\">MarketsandMarkets<\/a><br \/><strong>Contact Person:<\/strong> Mr. Aashish Mehra<br \/><strong>Email:<\/strong> <a href=\"https:\/\/www.abnewswire.com\/email_contact_us.php?pr=veterinary-vaccines-market-worth-113-billion-by-2025-key-players-zoetis-us-merck-us-boehringer-ingelheim-germany\" rel=\"nofollow\">Send Email<\/a><br \/><strong>Phone:<\/strong> 18886006441<br \/><strong>Address:<\/strong>630 Dundee Road  Suite 430<br \/><strong>City:<\/strong> Northbrook<br \/><strong>State:<\/strong> IL 60062<br \/><strong>Country:<\/strong> United States<br \/><strong>Website:<\/strong> <a href=\"https:\/\/www.marketsandmarkets.com\/Market-Reports\/animal-veterinary-vaccines-market-1233.html\" target=\"_blank\" rel=\"nofollow\">https:\/\/www.marketsandmarkets.com\/Market-Reports\/animal-veterinary-vaccines-market-1233.html<\/a><\/p>\n<p><object type=\"text\/html\" data=\"https:\/\/www.marketsandmarkets.com\/Market-Reports\/animal-veterinary-vaccines-market-1233.html\" style=\"width:900px; height:400px;\"><\/object><img decoding=\"async\" src=\"https:\/\/www.abnewswire.com\/press_stat.php?pr=veterinary-vaccines-market-worth-113-billion-by-2025-key-players-zoetis-us-merck-us-boehringer-ingelheim-germany\" alt=\"\" width=\"1px\" height=\"1px\" \/><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Veterinary Vaccines Market Size Estimation and Analysis of Wide Range of Growth Opportunities for Industry Players. According to the new market research report&nbsp;&#8220;Veterinary Vaccines Market by Disease (Swine Pneumonia, Avian Influenza, Rabies, Coccidiosis, Brucellosis, Canine Distemper), Type (Poultry, Livestock, Aquaculture, &hellip; <a href=\"https:\/\/www.abnewswire.com\/pressreleases\/veterinary-vaccines-market-worth-113-billion-by-2025-key-players-zoetis-us-merck-us-boehringer-ingelheim-germany_516020.html\">Continue reading <span class=\"meta-nav\">&rarr;<\/span><\/a><\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[401,405,417,406,403],"tags":[],"class_list":["post-516020","post","type-post","status-publish","format-standard","hentry","category-Business","category-Health-Medicine","category-Marketing-Sales","category-Pharmaceuticals-Biotech","category-UK"],"_links":{"self":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts\/516020","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/comments?post=516020"}],"version-history":[{"count":0,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts\/516020\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/media?parent=516020"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/categories?post=516020"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/tags?post=516020"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}